File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/sj.bjc.6602254
- Scopus: eid_2-s2.0-12344257911
- PMID: 15599381
- WOS: WOS:000225726600011
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells
Title | Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells |
---|---|
Authors | |
Keywords | Cell proliferation EGFR Id-1 Ovarian cancer |
Issue Date | 2004 |
Publisher | Nature Publishing Group. The Journal's web site is located at http://www.nature.com/bjc |
Citation | British Journal Of Cancer, 2004, v. 91 n. 12, p. 2042-2047 How to Cite? |
Abstract | Increased EGFR (epidermal growth factor receptor) expression has been reported in many types of human cancer and its levels are positively associated with advanced cancers. Recently, upregulation of Id-1 (inhibitor of differentiation or DNA binding) protein was found in over 70% of ovarian cancer samples and correlated with poor survival of ovarian cancer patients. However, the molecular mechanisms responsible for the role of Id-1 in ovarian cancer are not clear. The aim of this study was to investigate the effect of Id-1 on ovarian cancer proliferation and its association with the EGFR pathway. To achieve this, we transfected an Id-1 expression vector into three ovarian cancer cell lines and examined cell proliferation rate by flow cytometry and bromodeoxyuridine staining. We found that ectopic Id-1 expression led to increased cell proliferation demonstrated by increased BrdU incorporation rate and S-phase fraction. The Id-1-induced cell growth was associated with upregulation of EGFR at both transcriptional and protein levels. In contrast, inactivation of Id-1 through transfection of an Id-1 antisense vector resulted in downregulation of EGFR. Our results indicate that increased Id-1 in ovarian cancer cells may promote cancer cell proliferation through upregulation of EGFR. Our findings also implicate that Id-1 may be a potential target for the development of novel strategies in the treatment of ovarian cancer. © 2004 Cancer Research UK. |
Persistent Identifier | http://hdl.handle.net/10722/67856 |
ISSN | 2023 Impact Factor: 6.4 2023 SCImago Journal Rankings: 3.000 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhang, X | en_HK |
dc.contributor.author | Ling, MT | en_HK |
dc.contributor.author | Feng, H | en_HK |
dc.contributor.author | Wong, YC | en_HK |
dc.contributor.author | Tsao, SW | en_HK |
dc.contributor.author | Wang, X | en_HK |
dc.date.accessioned | 2010-09-06T05:58:54Z | - |
dc.date.available | 2010-09-06T05:58:54Z | - |
dc.date.issued | 2004 | en_HK |
dc.identifier.citation | British Journal Of Cancer, 2004, v. 91 n. 12, p. 2042-2047 | en_HK |
dc.identifier.issn | 0007-0920 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/67856 | - |
dc.description.abstract | Increased EGFR (epidermal growth factor receptor) expression has been reported in many types of human cancer and its levels are positively associated with advanced cancers. Recently, upregulation of Id-1 (inhibitor of differentiation or DNA binding) protein was found in over 70% of ovarian cancer samples and correlated with poor survival of ovarian cancer patients. However, the molecular mechanisms responsible for the role of Id-1 in ovarian cancer are not clear. The aim of this study was to investigate the effect of Id-1 on ovarian cancer proliferation and its association with the EGFR pathway. To achieve this, we transfected an Id-1 expression vector into three ovarian cancer cell lines and examined cell proliferation rate by flow cytometry and bromodeoxyuridine staining. We found that ectopic Id-1 expression led to increased cell proliferation demonstrated by increased BrdU incorporation rate and S-phase fraction. The Id-1-induced cell growth was associated with upregulation of EGFR at both transcriptional and protein levels. In contrast, inactivation of Id-1 through transfection of an Id-1 antisense vector resulted in downregulation of EGFR. Our results indicate that increased Id-1 in ovarian cancer cells may promote cancer cell proliferation through upregulation of EGFR. Our findings also implicate that Id-1 may be a potential target for the development of novel strategies in the treatment of ovarian cancer. © 2004 Cancer Research UK. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Nature Publishing Group. The Journal's web site is located at http://www.nature.com/bjc | en_HK |
dc.relation.ispartof | British Journal of Cancer | en_HK |
dc.subject | Cell proliferation | - |
dc.subject | EGFR | - |
dc.subject | Id-1 | - |
dc.subject | Ovarian cancer | - |
dc.subject.mesh | Blotting, Western | en_HK |
dc.subject.mesh | Cell Line, Tumor | en_HK |
dc.subject.mesh | Cell Proliferation | en_HK |
dc.subject.mesh | Female | en_HK |
dc.subject.mesh | Flow Cytometry | en_HK |
dc.subject.mesh | Humans | en_HK |
dc.subject.mesh | Inhibitor of Differentiation Protein 1 | en_HK |
dc.subject.mesh | Ovarian Neoplasms - metabolism | en_HK |
dc.subject.mesh | Receptor, Epidermal Growth Factor - metabolism | en_HK |
dc.subject.mesh | Repressor Proteins - metabolism | en_HK |
dc.subject.mesh | Transcription Factors - metabolism | en_HK |
dc.title | Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0007-0920&volume=91&spage=2042&epage=2047&date=2004&atitle=Id-1+stimulates+cell+proliferation+through+activation+of+EGFR+in+ovarian+cancer+cells | en_HK |
dc.identifier.email | Ling, MT:patling@hkucc.hku.hk | en_HK |
dc.identifier.email | Wong, YC:ycwong@hkucc.hku.hk | en_HK |
dc.identifier.email | Tsao, SW:gswtsao@hkucc.hku.hk | en_HK |
dc.identifier.authority | Ling, MT=rp00449 | en_HK |
dc.identifier.authority | Wong, YC=rp00316 | en_HK |
dc.identifier.authority | Tsao, SW=rp00399 | en_HK |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1038/sj.bjc.6602254 | en_HK |
dc.identifier.pmid | 15599381 | - |
dc.identifier.scopus | eid_2-s2.0-12344257911 | en_HK |
dc.identifier.hkuros | 97978 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-12344257911&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 91 | en_HK |
dc.identifier.issue | 12 | en_HK |
dc.identifier.spage | 2042 | en_HK |
dc.identifier.epage | 2047 | en_HK |
dc.identifier.isi | WOS:000225726600011 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Zhang, X=8299216200 | en_HK |
dc.identifier.scopusauthorid | Ling, MT=7102229780 | en_HK |
dc.identifier.scopusauthorid | Feng, H=7401736336 | en_HK |
dc.identifier.scopusauthorid | Wong, YC=7403041798 | en_HK |
dc.identifier.scopusauthorid | Tsao, SW=7102813116 | en_HK |
dc.identifier.scopusauthorid | Wang, X=7501854829 | en_HK |
dc.identifier.citeulike | 3961 | - |
dc.identifier.issnl | 0007-0920 | - |